Long-term Use of Continuous Subcutaneous Hydrocortisone Infusion Therapy in Patients with Congenital Adrenal Hyperplasia

BACKGROUND: In a phase 2 short-term (6 months) study of patients with congenital adrenal hyperplasia (CAH), continuous subcutaneous hydrocortisone infusion (CSHI) was found to be a safe, effective, and well-tolerated method of replacing cortisol with improved disease and patient related outcomes. OB...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Endocrinol (Oxf)
Egile Nagusiak: Mallappa, Ashwini, Nella, Aikaterini A., Sinaii, Ninet, Rao, Hamsini, Gounden, Verena, Perritt, Ashley F., Kumar, Parag, Ling, Alexander, Liu, Chia-Ying., Soldin, Steven J., Merke, Deborah P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166869/
https://ncbi.nlm.nih.gov/pubmed/30003563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13813
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak